ArticleEye (London, England)2026

Comparison of adverse renal events between ranibizumab and aflibercept in patients with diabetic macular oedema: A global network study.

Wan-Ju Annabelle Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.